1. Metabolic and Regulatory Pathways Involved in the Anticancer Activity of Perillyl Alcohol: A Scoping Review of In Vitro Studies.
- Author
-
Batista Brochado, Ana Carolina, Moraes, Júlia Alves de, Rodrigues de Oliveira, Bruna, De Souza Lima, Victor Hugo, Mariano, Eric Domingos, Karande, Sachin, Romasco, Tea, Leite, Paulo Emilio Correa, Mourão, Carlos Fernando, and Gomes Alves, Gutemberg
- Subjects
- *
CHEMICAL alcohol metabolism , *PROTEINS , *RESEARCH funding , *PHOSPHORYLATION , *PHENOMENOLOGICAL biology , *ANTINEOPLASTIC agents , *CELLULAR signal transduction , *BIOCHEMISTRY , *DESCRIPTIVE statistics , *PLANT extracts , *SYSTEMATIC reviews , *MEDLINE , *ADENOSINE triphosphatase , *CELL death , *ONLINE information services - Abstract
Simple Summary: Perillyl alcohol is a natural compound derived from plants, and it has shown promise as an anti-cancer agent in various types of cancer. This review explores how POH affects cancer cells by examining its impact on metabolic and regulatory pathways, such as those involved in cell cycle regulation and apoptosis. By understanding these mechanisms, researchers can identify new opportunities for cancer treatment and consider POH as a candidate for drug repurposing. The findings from this research may help develop novel therapies that are more effective and potentially less toxic, providing new avenues for cancer treatment. Background/Objectives: Perillyl alcohol (POH), a plant-derived compound, has demonstrated anti-tumor activity across various human cancers. Understanding the regulatory pathways through which POH exerts its effects is crucial for identifying new therapeutic opportunities and exploring potential drug repositioning strategies. Therefore, this scoping review aims to provide a comprehensive overview of the metabolic and regulatory pathways involved in the anticancer effects of POH, based on in vitro evidence. Methods: Following the PRISMA-ScR 2018 guidelines, a systematic search was conducted in the PUBMED, Web of Science, and Scopus databases. Results: A total of 39 studies were included, revealing that POH exerts its biological effects by modulating several pathways, including the regulation of cyclins, CDKs, and p21, thereby affecting cell cycle progression. It inhibits growth and promotes cell death by attenuating AKT phosphorylation, reducing PARP-1 activity, increasing caspase activity and the FAS receptor and its ligand FASL. Additionally, POH reduces ERK phosphorylation, inhibits RAS protein isoprenylation, and decreases Na/K-ATPase activity. Conclusions: In conclusion, this review delineates the key regulatory pathways responsible for mediating the biological effects of POH in cancer. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF